Rea Diagnostics SA

We develop technology to monitor high risk pregnancies

Rea developed the first at-home diagnostic test that tracks biochemical markers of preterm birth (PTB). Our solution allows doctors to continuously follow up pregnant women at risk of PTB to anticipate a potential early delivery.

Today, all of the medical examinations to monitor the risk of a PTB require invasive inspections of pregnant women. These tests have to be performed by a medical professional in a hospital, limiting significantly the number of pregnant women that can be tested.

Our technology could enable obstetricians to provide personalized prophylactic treatments to decrease neonatal mortalities and morbidities.

PTB is the leading cause of death among children <5 years of age &, every year, an estimated 15 million babies are born preterm.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

02.06.2025

MassChallenge Switzerland presents 2025 cohort (startupticker.ch)

22.01.2024

DOPPL and Rea Diagnostics get FIT Funding Boost (startupticker.ch)

No Jobs

Videos

A Kickers' World, Episode 6 REA co-founders CEO Loulia Kassem and CTO Erick Garcia

Pitch Startup Champions Seed Night 2020

Player is loading...

Rea: The smart pad

A Kickers' World, Episode 6 REA co-founders CEO Loulia Kassem and CTO Erick Garcia

REA

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Website

Venture Leaders Medtech

Rea Diagnostics SA

We develop technology to monitor high risk pregnancies

Headquarter:
Lausanne

Foundation Date:
February 2022

Technology:

  • Medtech

Sectors:

  • Consumer products
  • Biotech
  • Digital Health
  • Diagnostics
  • IoT
  • Medical devices
  • Sensors
  • Medtech
  • Patient monitoring
  • Wearable technologies

Support received

  • Support venture leaders
  • Support venturekick